IDH2-DT: A Potential Drug Target or Biomarker for Various Diseases

Target Name: IDH2-DT

NCBI ID: G105370966

IDH2-DT

Other Name(s): Uncharacterized LOC105370966 | LOC105370966 | IDH2 divergent transcript

IDH2-DT: A Potential Drug Target or Biomarker for Various Diseases

IDH2-DT (Uncharacterized LOC105370966) is a protein that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Its unique structure and function have made it an intriguing target for researchers to investigate. In this article, we will explore the IDH2-DT protein, its potential drug target status, and its potential clinical applications.

Structure and Function

IDH2-DT is a protein that is expressed in various tissues, including muscle, brain, and organs. Its primary function is to regulate the activity of the enzyme IDH2, which is a critical regulator of cellular metabolism. IDH2-DT has a unique structure that consists of a 166 amino acid protein with a calculated molecular mass of 19.9 kDa.

One of the key features of IDH2-DT is its ability to interact with IDH2, which is a 21-kDa protein that is involved in the metabolism of nucleotides. This interaction between IDH2-DT and IDH2 suggests that the protein plays a role in regulating the activity of IDH2, which is a potential drug target or biomarker for various diseases.

IDH2-DT has also been shown to interact with various proteins, including the transcription factor p53. This interaction between IDH2-DT and p53 suggests that the protein may be involved in the regulation of cellular growth and apoptosis, which are important processes that are affected in various diseases.

Potential Drug Target Status

The potential drug target status of IDH2-DT is based on its unique structure and interaction with various proteins. IDH2-DT has been shown to interact with IDH2, which is a known drug target for various diseases, including cancer. The interaction between IDH2-DT and IDH2 suggests that the protein may be a potential drug target for cancer.

IDH2-DT has also been shown to interact with the transcription factor p53, which is a known drug target for various diseases, including neurodegenerative diseases. The interaction between IDH2-DT and p53 suggests that the protein may be involved in the regulation of cellular growth and apoptosis, which are important processes that are affected in neurodegenerative diseases.

In addition to its potential drug target status, IDH2-DT has also been shown to play a role in the regulation of cellular metabolism, which is important in various diseases. The interaction between IDH2-DT and IDH2 suggests that the protein may be involved in the regulation of cellular metabolism, which is affected in diseases such as cancer, neurodegenerative diseases, and metabolic disorders.

Potential Clinical Applications

The potential clinical applications of IDH2-DT as a drug target or biomarker are vast. IDH2-DT has been shown to play a role in the regulation of cellular metabolism, which is important in various diseases. By targeting IDH2-DT, researchers may be able to develop new treatments for diseases such as cancer, neurodegenerative diseases, and metabolic disorders.

IDH2-DT has also been shown to interact with various proteins, including the transcription factor p53. This interaction suggests that the protein may be involved in the regulation of cellular growth and apoptosis, which are important processes that are affected in various diseases. By targeting IDH2-DT, researchers may be able to develop new treatments for diseases that are characterized by these processes, such as cancer and neurodegenerative diseases.

Conclusion

In conclusion, IDH2-DT is a protein that has been identified as a potential drug target or biomarker for various diseases. Its unique structure and function have made it an intriguing target for researchers to investigate. The potential clinical applications of IDH2-DT as a drug

Protein Name: IDH2 Divergent Transcript

The "IDH2-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IDH2-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets